SCHEMBL2861069

SCHEMBL2861069

COC(=O)c1ccc2[nH]nc(-c3ccc4ccccc4c3)c2c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALPL P05186 1/20 0.54
MAPK1 P28482 6/20 0.52
MAP2K4 P45985 5/20 0.52
CYP19A1 P11511 1/20 0.51
CYP11B1 P15538 1/20 0.51
CYP11B2 P19099 1/20 0.51
CDK4 P11802 1/20 0.51
CCNA2 P20248 1/20 0.51
CCND1 P24385 1/20 0.51
CDK2 P24941 1/20 0.51
CCND3 P30281 1/20 0.51
KDR P35968 1/20 0.51
MAPKAPK2 P49137 2/20 0.48
CSNK1D P48730 1/20 0.48
MAPKAPK3 Q16644 2/20 0.47
MAPK6 Q16659 2/20 0.47
SLC6A2 P23975 1/20 0.47
SLC6A4 P31645 1/20 0.47
SLC6A3 Q01959 1/20 0.47
PLAU P00749 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2855850 0.85 MAP2K4 (0.59) MAPK1MAP2K4CDK4CCNA2CCND1
SCHEMBL2860104 0.84 PIM1 (0.53) ALPLMAPK1MAP2K4CYP19A1CYP11B1
SCHEMBL5374570 0.84 MAP2K4 (0.59) MAPK1MAP2K4CDK4CCNA2CCND1
SCHEMBL2866668 0.82 ALOX15 (0.44) ALPLMAPK1MAP2K4CSNK1DKDM4E
SCHEMBL9986229 0.81 MAPK1 (0.58) MAPK1MAP2K4MAPKAPK3MAPK6MAPK3
SCHEMBL2866811 0.81 MAP2K4 (0.55) MAPK1MAP2K4CSNK1DMAPKAPK3MAPK6
SCHEMBL2860913 0.81 MAP2K4 (0.61) MAPK1MAP2K4CSNK1DMAPKAPK3MAPK6
SCHEMBL2867128 0.80 MAPK1 (0.58) MAPK1CSNK1DFLT3MAPK3
SCHEMBL2863068 0.79 TP53 (0.45) MAPK1MAP2K4KDRSLC6A3KDM4E
SCHEMBL5377524 0.79 MAPK10 (0.53) MAPK1MAP2K4MAPKAPK2SLC6A3KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
EP-1380576-B1 1H-INDAZOLE COMPOUNDS INHIBITING JNK EISAI R&D MAN CO LTD (JP) 2009-11-25 EP disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
CN-1300116-C 1H-indazole compounds EISAI CO LTD (JP) 2007-02-14 CN disclosed
US-6982274-B2 1H-indazole compound EISAI CO., LTD. (JP) 2006-01-03 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed
CN-1512987-A Novel 1H-indazole compound ������������ʽ���� 2004-07-14 CN disclosed
US-20040127538-A1 Novel 1h-indazole compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-07-01 US disclosed
EP-1380576-A1 NOVEL 1H-INDAZOLE COMPOUND Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203691-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 ALPL 4202/4885MAPK1 1/4885MAP2K4 61/4885
US-20040127538-A1 Novel 1h-indazole compound MAPK1, MAPK14, MAPK3 ALPL 4224/4885MAPK1 1/4885MAP2K4 53/4885
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 ALPL 4202/4885MAPK1 1/4885MAP2K4 61/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.